Зміни якості життя та критерії ефективності аортокоронарного шунтування в пацієнтів зі стабільною ішемічною хворобою серця і збереженою фракцією викиду лівого шлуночка

Ю.А. Борхаленко, О.Й. Жарінов, К.О. Міхалєв, О.А. Єпанчінцева, Б.М. Тодуров

Література 

1. Buziashvili YI, Sigaev IY, Khananashvili EM. et al. Evaluation of left ventricular diastolic function in patients with ischemic heart disease before and after coronary artery bypass surgery. The Russian Journal of Thoracic and Cardiovascular Surgery. 2001;4:30-35. (in Russ.).
2. Kovalenko VM, Lutay MІ, Sirenko YM. Cardiovascular disease. Classification, standards of diagnosis and treatment: Methodical recommendations of the Association of Cardiologists of Ukraine. Кyiv, 2010. (in Ukr.).
3. Lutai MI, Lysenko AF Medicinal treatment of stable angina pectoris. Methodical recommendations of the Working Group on Atherosclerosis and Chronic Chondritis of the Association of Cardiologists of Ukraine. Кyiv, 2013. (in Ukr.).
4. ATS Statement: Guidelines for the six – minute walk test. Amer J Respir Crit Care Med. 2002;166:111-117.
5. Bengtson A, Karlsson T, Herlitz J. On the waiting list for possible coronary revascularisation. Symptoms relief during the first year and association between quality of life and the very long-term mortality risk. Int J Cardiol. 2008;123(3):271-276.
6. Caine N, Harrison SCW, Sharples LD, Wallwork J. Prospective study of quality of life before and after coronary artery bypass grafting. BMJ. 1991;302:511-516.
7. Chocron S, Etievent JP, Viel JF. et al. Prospective study of quality of life before and after open heart operations. Ann Thorac Surg. 1996;61:153-157.
8. Endicott KM, Amdur RL, Greenberg MD, Trachiotis GD. B-type Natriuretic peptide predicts morbidity and long-term mortality in coronary artery bypass grafting and valve surgery. Innovations (Phila). 2016;11(6):439-443.
9. Falcoz PE, Chocron S, Laluc F. et al. Gender analysis after elective open heart surgery: a two-year comparative study of quality of life. Ann Thorac Surg. 2006;81:1637-1643.
10. Fox Amanda A, Marcantonio Edward R, Collard Charles D. et al. Elevated Peak Postoperative B-type Natriuretic Peptide Predicts Decreased Longer-Term Physical Function after Primary Coronary Artery Bypass Graft Surgery. Anesthesiology. 2011;114(4):807-816.
11. Hak T, Willems D, van der Wal G. et al. A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2004;13:417-426.
12. Herlitz J, Haglid M, Wiklund I. et al. Improvement in quality of life during 5 years after coronary artery bypass grafting. Coron Artery Dis. 1998;9(8):519-526.
13. Holm J, Vidlund M, Vanky F. et al. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery. Br J Anaesth. 2014;113(1):75-82.
14. Hunt JO, Hendrata MV, Myles PS. Quality of life 12 months after coronary artery bypass graft surgery. Heart Lung. 2000;29:401-411.
15. Kattainen E, Sintonen H, Kettunen R, Merilainen P. Health-related quality of life of coronary artery bypass grafting and percutaneous transluminal coronary artery angioplasty patients: 1-year follow-up. Int J Technol Assess Health Care. 2005;21:172-179.
16. Le Grande MR, Elliott PC, Murphy BM. et al. Health related quality of life trajectories and predictors following coronary artery bypass surgery. Health Qual Life Outcomes. 2006;4:49.
17. Loponen P, Luther M, Korpilahti K. et al. HRQOL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina. Scand Cardiovasc J. 2009;43(2):94-99.
18. Loponen P, Luther M, Korpilahti K. et al. Quality of life during 18 months after coronary artery bypass grafting. Eur J Cardiothor Surgery. 2007;(32):77-82.
19. Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
20. Murad Junior Jamil Alli, Nakazone Marcelo Arruda, Machado Mauricio de Nassau, de Godoy Moacir Fernandes. Predictors of mortality in cardiac surgery: brain natriuretic peptide type B. Braz. J Cardiovasc Surg. 2015;30(2):182-187.
21. Nagueh SF, Appleton CP, Gillebert TC. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:1525-2167.
22. Peric Vladan M, Borzanovic Milorad D, Stolic Radojica V. et al. Severity of angina as a predictor of quality of life changes six months after coronary artery bypass surgery. Ann Thorac Surg. 2006;81:2115-2120.
23. Peric Vladan M, Borzanovic M, Stolic R. et al. Predictors of worsening of patients’ quality of life six months after coronary artery bypass surgery. J Card Surg. 2008;23:648-654.
24. Peric Vladan M, Stolic Radojica V, Jovanovic Aleksandar N. et al. Severity of angina as a predictor of quality of life changes six months after coronary artery bypass surgery. Ann Thorac Surg. 2006;81:2115-2120.
25. Ross AC, Ostrow L. Subjectively perceived quality of life after coronary artery bypass surgery. Am J Crit Care. 2001;10(1):11-16.
26. Rumsfeld JS, Magid DJ, Plomondon ME. et al. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol. 2003;41(10):1732-1738.
27. Seok-Jae H, Vojtech M, Barry A. Implications of coronary artery disease in heart failure with preserved ejection fraction (Mayo clinic). J Amer Coll Cardiology. 2014;63:2817-2827.
28. Sharma R, Anker SD. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Eur. Heart J. 2002;23:886-891.
29. Spertus JA, Winder JA, Dewhurst TA. et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25(2):333-341.
30. Spertus JA, Winder JA, Dewhurst TA. et al. Monitoring the quality of life in patients with coronary artery disease. Amer J Heart. 1994;74:1240-1244.
31. Terou I, Shigenori M, Terumi H. et al. Left Ventricular diastolic dysfunction in coronary artery disease: effects of coronary revascularization. Clin Cardiol. 1992;15:577-581.
32. Yamamoto K, Redfield MM, Nishimura RA. Analysis of left ventricular diastolic function. Heart. 1996;75(2):27-35.
33. Yancy CW, Jessup M, Bozkurt B. et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327.
34. Yun KL, Sintek CF, Fletcher AD. et al. Time related quality of life after elective cardiac operation. Ann Thorac Surg. 1999;68(4):1314-1320.
35. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): Conceptual framework and item selection. Medical Care. 1992;30:473-483.
36. Windecker S, Kolh P, Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35:2541-2619.